The Costs of Cancer Drugs and Unreliable FDA Drug Approvals (6-10-2024)

June 10, 2024

- This evenings in oncology program will be a virtual (online) event. -

Overview

This program will dive into the escalating costs of cancer drugs, examining factors such as R&D expenses and market dynamics. Participants will have a better understanding of the economic burden of cancer care and issues with various clinical trials and FDA drug approvals, with an emphasis on patient safety and healthcare costs. Potential solutions will also be highlighted to reduce drug costs and improve reliability of clinical trial data, offering insights into value-based pricing, competition enhancement and transparency measures.

Learning Objectives:

1. Describe the increasing costs of cancer drugs and factors contributing to the rising cost
2. Review the economic burden of cancer care
3. Identity problems in various clinical trials and unreliable FDA drug approvals
4. Discuss solutions to reduce costs of cancer drugs and improve reliability of clinical trial data

BCOP pharmacists can use up to 20 ACPE credits toward BCOP recertification

 

Membership

Pricing      

OPN Member$0
Non OPN Members $5

    Click Here if you would like to learn more about the benefits of OPN Membership.

     

    Target Audience

    This activity is intended for oncology pharmacists, nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers in the California area involved in the care of cancer patients.

    Presented By

                                                    

    Course summary
    Available credit: 
    • 1.00 ACPE Pharmacy
      The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 1.00 credit by the Washington State Pharmacy Association.

      This activity is approved for up to 1.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21--L01-P | Activity Type: Live| Start/End date: Mon, 06/10/2024 - 5:55pm-Mon, 06/10/2024 - 7:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
    • 1.00 AMA PRA Category 1 Credit™

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

      Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Course opens: 
    04/17/2024
    Course expires: 
    07/13/2024
    Event starts: 
    06/10/2024 - 5:55pm PDT
    Event ends: 
    06/10/2024 - 7:30pm PDT
    Cost:
    $5.00
    Add to calendar: 
    Rating: 
    0

    Agenda

    All Times Listed are for the Pacific Standard Time Zone

    Monday, June 10, 2024

    5:55pmWelcome and Introduction
    » Mimi Lo, PharmD, BCPS, BCOP - Clinical Pharmacist University Of California, San Francisco
    6:00pmThe Costs of Cancer Drugs and Unreliable FDA Drug Approvals
    » Amir Ali, PharmD, BCOP Hematology/Oncology Clinical Pharmacist Specialist Adjunct Assistant Professor USC Mann School of Pharmacy Los Angeles, CA
    7:00pmClosing Comments
    » Mimi Lo, PharmD, BCPS, BCOP
    Online Livecast
    United States

    Faculty

    Mimi Lo, PharmD, BCPS, BCOP

    Dr. Mimi Lo is a hematology/oncology/blood and marrow transplant (BMT) clinical pharmacist at the University of California San Francisco (UCSF) Medical Center and serves as an assistant clinical professor at the UCSF School of Pharmacy. She is Board Certified in Pharmacotherapy and Oncology Pharmacy. Dr. Lo received her Doctor of Pharmacy degree from Purdue University College of Pharmacy. She completed her pharmacy practice residency and a specialty residency in oncology at UW Medicine in Seattle, WA.

    Currently, she specializes in malignant hematologic diseases, blood and marrow transplantation, and immune effector cell (IEC) therapy. Her practice site includes both the acute and ambulatory care settings. Her areas of research interest include treatment outcomes in adult malignant hematology/BMT/IEC patients and geriatric oncology. Dr. Lo also serves on the Board of Pharmacy Specialties (BPS) Oncology Pharmacy Specialty Council and coordinates the Northern California Oncology Pharmacy Network (NCOPN).

     

    Amir Ali, PharmD, BCOP 

    Dr. Amir Ali is a board-certified Hematology/Oncology Clinical Pharmacist at University of Southern California (USC) Norris Comprehensive Cancer Center. Amir received his PharmD at UCSF and completed his PGY1 residency at Kaiser Permanente Orange County. He then went on to complete his PGY2 oncology/hematology residency at USC. Amir currently practices as a BMT/Cellular therapy specialist at the USC Norris Comprehensive Cancer Hospital. He also serves as the PGY2 residency program coordinator along with his roles on the system-wide USC Residency Preceptor Development and Cellular Therapies Committees. Amir’s background also includes extensive national presentations and various grant research topics. His research, publications, and presentations span topics of hematology, oncology, BMT, and ID. He is the primary investigator on three Phase 4 studies with grants totaling over $200,000. Amir serves on the Board of Directors for the Oncology Pharmacy Network of California and is on the program planning committee for The American Society for Transplantation and Cellular Therapy. Amir has received awards as 40 Under 40 in Cancer, ASTCT New Practitioner, Project of the Year and Professor of the Year at the USC Mann School of Pharmacy..

    Available Credit

    • 1.00 ACPE Pharmacy
      The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 1.00 credit by the Washington State Pharmacy Association.

      This activity is approved for up to 1.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21--L01-P | Activity Type: Live| Start/End date: Mon, 06/10/2024 - 5:55pm-Mon, 06/10/2024 - 7:30pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
    • 1.00 AMA PRA Category 1 Credit™

      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.

      Horizon CME designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Price

    Cost:
    $5.00
    Please login or register to take this course.

    Required Hardware/software

    Access to the internet is required.

    Supported Browsers:

    Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

    Google Chrome 28.0+ for Windows, Mac OS, or Linux

    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

    Safari 6.0+ for Mac OSX 10.7 and above


    Supported Phones & Tablets:

    Android 4.0.3 and above

    iPhone/iPad with iOS 6.1 or above

    How to obtain credit for attendance (eligibility requirement and process for obtaining certificate)
    To receive documentation of credit, participants must:

    1. Login to the educational portal

    2. Attend the educational activity

    3. Complete the online evaluation form. The last day to access the evaluation is July 11, 2024 at 11:59pm PST* 

    4. Attest to the number of hours in attendance in order to submit CE

    *Requests from learners to claim credit after the evaluation closes will not be granted